Leon Rapoport, Bernardo
Garcia-Morillo, Marcial
Font, Carme
Samoon, Zarka
Jabbar, Adnan Abdul
Kourie, Hampig Raphael
Kayumba, Aline
Esposito, Francis
Popescu, Razvan Andrei
García-Gómez, Jesus
Heyman, Liezl
Smit, Teresa
Krendyukov, Andriy
Mathieson, Nicola
Cooksley, Tim
Anderson, Ronald
Klastersky, Jean
Funding for this research was provided by:
University of Pretoria
Article History
Received: 24 February 2023
Accepted: 23 September 2023
First Online: 13 October 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The study protocol and all amendments were reviewed by the independent ethics committee or institutional review board for each center. The ethics approval was obtained from the Ethics Review Committee of The Aga Khan University (Pakistan; Reference number: 2019–0827-2451), Hotel-Dieu de France Ethics Committee of the Université Saint-Joseph de Beyrouth (Lebanon; Reference number: CEHDF 1038), Ethics Committee Northwest and Central Switzerland (EKNZ, Switzerland; Reference number: 2018–01603), Ethics Committee of Institute Jules Bordet (Belgium, Reference number: B079201628399), Pharma-Ethics, an Independent Research Ethics Committee (South Africa, Reference number: 161115075), and Clinical Research Ethics Committee of the Hospital Clinic de Barcelona (Spain; Reference number: HCB/2017/0661). Informed consent was obtained from each patient in writing before enrolment in the study.
: All authors give consent for the publication of the manuscript in the Journal, “Supportive Care in Cancer”.
: BLR reports a research grant, personal fees, advisory boards, speaker engagements from Novartis and Sandoz, and personal fees and speaker engagements from Amgen South Africa, during the conduct of the study. MGM, CF, ZS, AAJ, HRK, FE, RAP, JG, LH, TS, TC, RA and JK have no relevant financial or non-financial interests to disclose. AK was a part of a study that received research grant from Sanofi. AK and NM are current or previous employees of Sandoz/Hexal AG.